Predicting Severe Dengue: StratifiDen™ Dengue Prognostic Test
by Press Release from Outbreak News Today on (#4JJEP)
StratifiCarea Inc, a spinoff from the National University of Singapore (NUS), is revolutionizing how patients are managed and treated in the world. Their flagship product, StratifiDena, is the world's first Dengue prognostic test. Government, insurers, and hospitals are lauding the early results of the StratifiDen test, given its ability to predict the risk of Severe ["]
The post Predicting Severe Dengue: StratifiDena Dengue Prognostic Test appeared first on Outbreak News Today.